| Old Articles: <Older 48771-48780 Newer> |
|---|
 |
The Motley Fool
May 20, 2011
Andrea Kalvesmaki |
Johnson & Johnson's Billion-Dollar Move Orthopedics are the name of the game for this company's future earnings.   |
Chemistry World
May 20, 2011
Sarah Houlton |
Takeda expands into Europe with Nycomed deal Japanese pharma company Takeda is to acquire Swiss-headquartered rival Nycomed for 9.6 billion. If the antitrust authorities give the go-ahead, the takeover should be completed by late summer. |
The Motley Fool
May 20, 2011
Cindy Johnson |
Level 3 Communications and Global Crossing Shares Popped: What You Need to Know Level 3 Communications popped 10%, and Global Crossing popped 11%, in intraday trading today, after Level 3 filed an update on the companies' planned merger. |
The Motley Fool
May 20, 2011
Sean Williams |
What's Wrong With Aeropostale? Aeropostale is having an identity crisis. |
The Motley Fool
May 20, 2011
Travis Hoium |
Jumping Back on the Las Vegas Sands Bandwagon Melco Crown has been my top gaming pick -- but it might be time to change sides. |
The Motley Fool
May 20, 2011
Brian Orelli |
Abbott Hits a Triple Not a home run, but Trilipix will likely stay on the market. |
The Motley Fool
May 20, 2011
Dan Caplinger |
Learn This Lesson From LinkedIn Today, one group of investors doubled their money. Another group took a whopping 20% loss. That's not all that unusual -- except that all of those folks were investing in the same stock. |
The Motley Fool
May 20, 2011
G. David Frye |
RIP, RIMM? It's not too late to turn this thing around. |
The Motley Fool
May 20, 2011
Anand Chokkavelu |
7 Great Stocks Some Wall Street Idiots Are Missing Capitalize on the short-sighted insight of the Street. |
The Motley Fool
May 20, 2011
Alex Pape |
Rising Stars Trade: Cover Strayer Education It's time to take advantage of a mispricing on the for-profit educator. |
| <Older 48771-48780 Newer> Return to current articles. |
